Objective: Little is known concerning pancreatic polypeptide (PP) in weight loss and in childhood obesity. Methods: Fasting PP, leptin and insulin concentrations were determined in 38 obese children and compared with 35 lean children of the same age, gender and pubertal stage. Furthermore, changes of PP concentrations over a 1-year period were analyzed in the obese children participating in a weight loss intervention program. Results: Obese children had significantly (Po0.01) lower PP, and higher leptin and insulin levels compared to lean children. In multiple linear regression analysis, PP was significantly negatively correlated to body mass index (Po0.01), but not to leptin, insulin, age, gender and pubertal stage. Changes of PP did not significantly correlate to changes of insulin (r ¼ 0.07, P ¼ 0.343) and leptin (r ¼ À0.02, P ¼ 0.459). The substantial weight loss in 17 children led to a significant (Po0.05) increase in PP and decrease in insulin and leptin. In the 21 children without substantial weight loss, there were no significant changes in PP, insulin and leptin. Conclusions: PP concentrations are decreased in obese children and independent of age, gender, pubertal stage, leptin and insulin. The decrease of PP in obese children normalized after weight loss. Therefore, low PP concentrations reflect the overweight status, rather than cause it.
Introduction
Satiety signals generated by the gastrointestinal tract include many peptides such as glucagon-like peptide 1, oxyntomodulin and cholecystokinin, as well as the pancreatic polypeptide family. 1 These gastrointestinal hormones are known as short-term satiety signals in contrast to the long-term satiety signals leptin and insulin. [1] [2] [3] The pancreatic polypeptide family of peptides consists of the structural similar endocrine peptides, pancreatic polypeptide (PP) and peptide YY (PYY), and the neuronally derived peptide, neuropeptide Y (NPY). These peptides bind with to all the NPY receptors, but PP and PYY preferentially bind to Y4, Y2 and Y1
receptors, which are present in both the brainstem and arcuate nucleus.
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The 36-amino-acid peptide PP is produced under vagal control by the peripheral cells of the endocrine pancreatic islets, and to a lesser extent in the exocrine pancreas, colon and rectum in response to a meal and to insulin-induced hypoglycemia. 1, [5] [6] [7] PP has been reported to reduce food intake in several animal models. 4 In contrast to centraladministered PP, which increases food intake in many species, 2, 4, 8, 9 peripherally injected PP induced a negative energy balance in mice by increasing energy expenditure and decreasing food intake. [8] [9] [10] Following peripheral administration of PP, the expression of hypothalamic orexigenic neuropeptides NPY and orexin mRNA is significantly reduced. 11 PP may also exert some anorectic action via the vagal pathway to the brainstem, as vagotomy seems to reduce its efficacy. 11 Mice that overexpress PP have reduced weight gain and decreased food intake. 12 In humans, administration of pharmacological doses of PP has also been shown to decrease food intake over the following 24 h. 13, 14 Furthermore, PP inhibits gastric emptying rate, exocrine pancreatic secretion and gallbladder motility. 15 In obese humans, studies concerning PP values have demonstrated conflicting results. Some studies found no difference between lean and obese subjects, [16] [17] [18] whereas other studies demonstrated lower fasting PP levels in obese subjects. [19] [20] [21] If PP levels are decreased in obese subjects, this could reflect a consequence of overweight or, on the other hand, a cause of overweight as PP affect food intake. To differentiate these two possibilities, long-term studies in obese subjects losing weight are necessary. Studies in obese humans with weight loss after gastric surgery have demonstrated stable 18, 22 and decreasing PP values. 23, 24 But it is difficult to distinguish between the effect of surgery on the gastrointestinal (GI) tract and the reduction of body weight on gastrointestinal hormone levels in these studies, because the decreased postprandial PP release after surgery on the GI tract may be in part due to the absence of gastric and duodenal food stimuli, vagal injury and lower blood glucose, which mainly regulate PP secretion. 5, 25 Even less is known about the role of PP in pediatric obesity. Because of these conflicting results, and the lack of studies concerning PP in obese children and in obese subjects with weight loss based on diet, we studied PP levels in obese and normal weight children and its relation to insulin and leptin. The aims of this study were to determine whether (1) PP levels are decreased in obese children and (2) this potential decrease of PP levels in obesity is reversible in weight loss owing to an obesity intervention program.
Materials and methods
We examined anthropometrical markers and fasting serum PP, leptin, glucose and insulin concentrations in 38 obese Caucasian children and 35 lean healthy Caucasian children of similar age, gender and pubertal stage. Furthermore, the obese children were studied before and after participating in the 1-year obesity intervention program 'Obeldicks'. This outpatient intervention program for obese children is based on a program of physical exercise, nutrition education and behavior therapy including individual psychological care of the child and his/her family and is described in detail elsewhere. 26, 27 Children with endocrine disorders, premature adrenarche or syndromal obesity were excluded from the study. Obesity was defined according to the body mass index (BMI) 97th percentile according to the definition of the International Task Force of Obesity using populationspecific data. 28, 29 Height was measured to the nearest centimeter using a rigid stadiometer. Weight was measured unclothed to the nearest 0.1 kg using a calibrated balance scale. Because BMI is not normally distributed in childhood, we used the LMS method to calculate standard deviation score (SDS)-BMI as measurement for the degree of overweight, which summarizes the data in terms of three smooth age-specific curves called L (lambda), M (mu) and S (sigma) based on German population-specific data. 28, 29 The M and S curves correspond to the median and coefficient of variation (CV%) BMI for German children at each age and gender, whereas the L curve allows for the substantial age-dependent skewness in the distribution of BMI. 28 The assumption underlying the LMS method is that after Box-Cox power transformation, the data at each age are normally distributed. 29 The triceps and subscapularis skinfold thicknesses were measured in duplicate by using a caliper and averaged to calculate the percentage of body fat using a skinfold thickness equation with the following formulas:
30 boys:
body fat % ¼ 0.783 (skinfold thickness subscapularis þ triceps in mm) þ 1.6; girls: body fat % ¼ 0.546 (skinfold thickness subscapularis þ triceps in mm) þ 9.7. The pubertal developmental stage was determined according to Marshall and Tanner and categorized into two groups (prepubertal: boys with pubic hair and gonadal stage I, girls with pubic hair stage and breast stage I; pubertal: boys with pubic hair or gonadal stage XII and girls with pubic hair stage or breast stage XII).
Blood sampling was performed in the fasting status at 0800. Serum PP concentrations were measured by a specific and sensitive radioimmunoassay (RIA) in duplicate using an iodine-labeled tracer ( 125 I-PP, Phoenix Pharmaceuticals, Inc., Belmont, CA, USA). The antibody does not cross-react with PYY, NPY, or other known gastrointestinal hormones. The intra-and inter-assay CV% were o10%. The sensitivity was 10 fmol/ml. Serum leptin levels were measured by commercially available RIA (Human Leptin RIA, Mediagnost, Reutlingen, Germany; intra-and inter-assay CVs o10%, sensitivity 0.1 ng/ml). Insulin concentrations were measured by microparticle-enhanced immunometric assay (MEIAt, Abbott, Wiesbaden, Germany). Glucose levels were determined by colorimetric test using a Vitrost analyzer (Ortho Clinical Diagnostics, Neckargmuend, Germany). Intra-and inter-assay CVs were o5% in both methods. Homeostasis model assessment (HOMA) was used to detect the degree of insulin resistance. 31 The resistance can be assessed from the fasting glucose and insulin concentrations by the formula:
Substantial weight loss over the 1-year intervention was defined by a decrease in SDS-BMI X0.5, because with a reduction of o0.5 SDS-BMI, no improvement of insulin resistance and cardiovascular risk factors could be measured in obese children. 32, 33 Statistical analysis was performed using the Winstat 
Results
The age, stages of puberty, gender, degree of overweight (BMI, SDS-BMI), leptin, insulin, glucose and PP levels of the 38 obese and 35 lean children are shown in Table 1 . Obese children demonstrated significantly higher insulin resistance index (HOMA), leptin and insulin levels, and lower PP concentrations compared to the lean children, whereas lean and obese children did not significantly differ in terms of age, gender and pubertal status.
The changes of PP, insulin resistance index (HOMA), insulin and leptin levels over the 1-year period in the 17 obese children with substantial weight loss and the 21 obese children without substantial weight loss are shown in Table 2 . The substantial weight loss led to a significant increase in PP concentrations, and decrease of leptin and insulin levels, respectively, insulin resistance index (HOMA).
In the obese children without substantial weight loss, there were no significant changes in insulin resistance index (HOMA), insulin, leptin and PP levels.
At baseline, there were no significant differences in age (P ¼ 0.285), gender (P ¼ 0.711), pubertal stage (P ¼ 0.419) and SDS-BMI (P ¼ 0.491) between the obese children with and without substantial weight loss. Furthermore, glucose (P ¼ 0.573), insulin (P ¼ 0.254), HOMA (P ¼ 0.175), leptin (P ¼ 0.188) and PP concentrations (P ¼ 0.111) did not significantly differ between the children of the two groups. One year later, triceps skinfold thickness (Po0.001), subscapularis skinfold thickness (Po0.001), percentage body fat (Po0.001), insulin (P ¼ 0.033), insulin resistance index (HOMA) (P ¼ 0.044) and leptin (P ¼ 0.002) concentrations were significantly lower and PP levels (P ¼ 0.049) were significantly increased in the children with substantial weight loss as compared to the children without substantial weight loss.
In the 1-year follow-up, changes in PP concentrations were significantly correlated to baseline PP values (r ¼ À0.47, P ¼ 0.002, see Figure 1 ), whereas changes of PP were not significantly related to changes of HOMA (r ¼ 0.08, P ¼ 0.315), insulin (r ¼ 0.07, P ¼ 0.343) and leptin (r ¼ À0.02, P ¼ 0.459) levels. In the multiple regression analysis, changes of PP were not significantly related to changes of HOMA (P ¼ 0.548), changes of leptin (P ¼ 0.701) and changes of insulin (P ¼ 0.162).
In the 73 obese and normal weight children, PP correlated significantly negatively to BMI (r ¼ À0.44, Po0.001), SDS-BMI (r ¼ À0.50, Po0.001), leptin (r ¼ À0.32, P ¼ 0.002), weakly to insulin (r ¼ À0.22, P ¼ 0.033) and insulin resistance index (HOMA) (r ¼ À0.20, P ¼ 0.040), but not to age (r ¼ À0.08, P ¼ 0.244). In direct multivariate linear regression analysis (r 2 ¼ 0.23, n ¼ 73), PP was significantly negatively correlated to BMI (coefficient À7.2, 95% confidential interval À13.4 to À2.1, Po0.001), whereas PP demonstrated no significant correlation to age (P ¼ 0.244), gender (P ¼ 0.644), stage of puberty (P ¼ 0.323), leptin (P ¼ 0.905) and insulin concentrations (P ¼ 0.338). 
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The PP levels of the 41 girls (PP in median 52, IQR 23-88 fmol/ml) did not significantly (P ¼ 0.965) differ from the PP concentrations of the 32 boys (PP in median 53, IQR 25-77 fmol/ml), while boys and girls did not differ in respect of age (P ¼ 0.982) and SDS-BMI (P ¼ 0.417).
Discussion
This is the first study analyzing not only the cross-sectional relationships between PP, leptin, insulin and weight status in childhood, but also the long-term changes of PP, insulin and leptin concentrations after weight reduction in one sample of obese children. We could demonstrate that obese children had significantly lower PP levels compared to lean children. PP levels increased significantly in obese children who substantially reduced their overweight in contrast to obese children without substantial weight loss over a 1-year period.
Our findings of decreased fasting PP levels in obese children are in concordance with most studies in obese adults, [19] [20] [21] whereas only a few studies consisting of a small number of subjects found no difference between lean and obese subjects. [16] [17] [18] It could be questioned whether low PP levels may contribute to obesity as circulating PP concentrations decrease appetite in humans. 1,2 However, this contribution appears to be more complex than anticipated because of the seemingly opposite effects of fasting and postprandial PP concentrations on the risk of future weight gain in a prospective study in Pima Indians. 34 The increase in PP levels in response to a meal was negatively associated with an increase in body weight at a follow-up of 5 years, whereas high fasting PP level at baseline was positively associated with increasing body weight. Most importantly, lower PP levels in obese humans are a consequence rather than a cause of obesity, as we demonstrated that the lower PP concentrations in obese children tend to normalize after substantial weight loss. The five studies in obese adults losing weight demonstrated stable PP 18, 22, 35 or decreasing PP levels. 23, 24 As these studies were performed either (1) in a very small number of subjects (n ¼ 7), who had only a very moderate weight loss, 35 or (2) weight loss was achieved by gastric surgery, 18, [22] [23] [24] these facts may explain the differences. It is difficult to distinguish between the effect of surgery and the reduction of body weight on gastrointestinal hormones in these studies, because the decreased postprandial PP release after surgery on the GI tract may be in part owing to the absence of gastric PP in obese children T Reinehr et al and duodenal food stimuli, vagal injury and lower blood glucose, which mainly regulate PP secretion. 5, 25 As PP concentrations are decreased in obesity and increase in weight loss, PP levels seem to reflect long-term energy stores. It is not clear, how obesity can lead to decreased fasting PP levels in humans. The release of PP after a meal occurs in proportion to the fat and calories ingested, and levels remain elevated for hours postprandially, also influencing fasting PP values. 1, 36 As the postprandial release of PP is reduced in obese subjects, 4, 19, [37] [38] [39] this may explain the lower fasting PP levels in obese subjects. As PP concentrations were not related to the adipocyte-derived hormone leptin, and the changes of PP concentrations were not correlated to the changes of leptin, a direct link between adipose tissue and PP levels seems unlikely. It could be speculated that low baseline levels of PP may be predictive to weight loss in obesity intervention programs as changes of PP levels were significantly negatively related to baseline concentrations of PP, and PP levels of obese children with substantial weight loss tended to be lower -but without significance -compared to the obese children with stable weight status over the 1-year period. This hypothesis has to be evaluated in further large interventions studies.
In the uni-and multivariate regression analyses, no significant correlations between PP concentrations and age, pubertal stage and gender were found. PP correlated weakly to insulin and insulin resistance index (HOMA) in univariate analyses, but PP did not correlate to insulin in the multiple linear regression analysis adjusted for degree of overweight. Most importantly, the changes of PP did not correlate to the changes of insulin concentrations or insulin resistance index in the longitudinal analysis. Therefore, the secretion of PP and insulin in the pancreas does not seem to be associated.
This study has a few potential limitations. First, BMI percentiles were used to classify overweight. Although BMI is a good measure for overweight, one needs to be aware of its limitations as an indirect measure of fat mass. Secondly, HOMA model is only an assessment of insulin resistance and clamp studies are the gold standard to analyze insulin resistance. As the HOMA model correlated to clamp studies, it is a good method to study insulin resistance in field studies. 40 Thirdly, we measured PP levels only in the fasting status and not postprandially during weight loss. Because impaired PP release in response to a meal was reported in obese subjects, 19 postprandially PP levels should be studied in subjects loosing weight. Fourthly, we did not measure PP concentrations between baseline and the end of the 1-year study period. Therefore, we could not analyze short-term changes of PP levels. Finally, the obese and lean children probably differed in dietary and physical activity levels. These differences may account for the observed differences in PP concentrations between lean and obese subjects and the changes of PP levels in weight loss. Conversely, measuring dietary and physical activity levels by questionnaires, dietary records or self-reporting are very susceptible to underreporting especially in obese children. 41 In summary, PP levels were independent of leptin, insulin, age, gender and pubertal stage, and were decreased in obese children. This change tended to normalize after weight loss. Therefore, low PP levels in obese children are a consequence rather than a cause of obesity. Further prospective research in obese subjects with weight loss performing multiple PP determinations especially in response to a meal is necessary to study the effect of weight status on PP concentrations in humans.
